Company news

Shanghai Yizhong Pharmaceutical Co. Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Announcement on "Corporate Value and Return Enhancement" Action Plan 2025

June 6, 2025

Announcement on Resolutions of the 2024 Annual General Meeting

May 29, 2025

Announcement on Plan of Shareholding Reduction by Shareholders through Call Auction

May 20, 2025

Notice on Convening the 2024 Annual General Meeting

May 8, 2025

Announcement on Attending the 2024 Annual Collective Performance Briefing for Innovative Drug Companies on SSE STAR Market and the Q1 2025 Performance Briefing

April 25, 2025

Special Report on Deposit and Use of Raised Funds in 2024

April 22, 2025

Indicative Announcement on Equity Change of Shareholders Reaching an Integral Multiple of 1%

March 25, 2025

Announcement of the Vesting Results and Stock Listing for the Reserved Grant of Shares in the 2022 Restricted Stock Incentive Plan's Initial Vesting Period

March 7, 2025

Announcement on Preliminary Earnings Estimate for 2024

February 27, 2025

Announcement on the Resignation of Non-independent Director

January 17, 2025

Announcement on Implementation Result of Repurchasing Shares and Share Changes

December 26, 2024

Announcement of the Vesting Results and Stock Listing for the First Grant of Shares in the 2022 Restricted Stock Incentive Plan's Initial Vesting Period

December 16, 2024

Announcement on Convening the Q3 2024 Performance Briefing

December 10, 2024

Announcement on Progress in Repurchasing Shares through Call Auction

December 3, 2024

Announcement on Inclusion of Core Product of Paclitaxel Polymer Micelles for Injection into the Catalogue Of Drugs For Basic National Medical Insurance

November 28, 2024

Announcement on Resolution of the 8th Meeting of the 2nd Board of Directors

November 26, 2024

Announcement on Resolution of the 7th Meeting of the 2nd Board of Supervisors

October 28, 2024

Announcement on Obtaining Notice of Approval for Drug Clinical Trials

October 15, 2024

Announcement on Convening the 2024 Semi-annual Performance Briefing

October 9, 2024

← Newer news releases